Article Details
Retrieved on: 2023-01-10 10:55:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Both Aduhelm and Leqembi are monoclonal antibodies that target amyloid-beta plaque reduction. Both drugs also received FDA accelerated approval, ...
Article found on: www.fool.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here